About Engineering for All
Engineering for All is a company based in Yokneam Illit (Israel) founded in 2016 by Yoel Ezra. Engineering for All has raised $7.4 million across 2 funding rounds from investors including Maccabi Health Services, unknown and Arc Impact. Engineering for All offers products and services including RevDx™. Engineering for All operates in a competitive market with competitors including Serum Institute of India, Vaxcyte, Vir Biotechnology, Biological E and Freeline, among others.
- Headquarter Yokneam Illit, Israel
- Founders Yoel Ezra
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.4 M (USD)
in 2 rounds
-
Latest Funding Round
$6.5 M (USD), Series A
Apr 07, 2024
-
Investors
Maccabi Health Services
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Engineering for All
Engineering for All offers a comprehensive portfolio of products and services, including RevDx™.
Portable tool for instant complete blood count results
People of Engineering for All
Unlock access to complete
Funding Insights of Engineering for All
Engineering for All has successfully raised a total of $7.4M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.5 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Engineering for All
Engineering for All has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Maccabi Health Services, unknown and Arc Impact.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Early-stage digital health ventures are funded and supported.
|
Locked | Locked | Locked |
Investor details for Engineering for All
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Engineering for All
Investment portfolio details for Engineering for All
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Engineering for All
Detailed financials for Engineering for All
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Engineering For All Comparisons
Peer comparison for Engineering for All
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Engineering for All
Engineering for All operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Serum Institute of India, Vaxcyte, Vir Biotechnology, Biological E and Freeline, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccines and immuno-biological drugs for infectious diseases are manufactured.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of infectious diseases
|
|
| Locked | Locked | Locked |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| Locked | Locked | Locked |
Gene therapy platform is developed for chronic disease treatments.
|
|
| Locked | Locked | Locked |
AAV-based gene therapies for rare diseases are developed.
|
Detailed competitors of Engineering for All
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Engineering For All
Complete news archive for Engineering for All
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Engineering for All
Engineering for All was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Engineering for All is headquartered in Yokneam Illit, Israel. It is registered at Yokneam Illit, North District, Israel.
Yoel Ezra is the current CEO of Engineering for All. They have also founded this company.
Engineering for All is a funded company, having raised a total of $7.4M across 2 funding rounds to date.
Engineering for All was founded in 2016 in Yokneam Illit, Israel, and operates in the medical diagnostics sector. A hand-held programmable device called the RevDx system is offered for automatic hematology tests and infectious disease diagnostics. This AI-based platform integrates optomechanics, electrochemistry, and bioengineering technologies. The device is intended for use in primary care settings, home hospitalization, and remote locations requiring disease diagnosis.
Engineering for All's top competitors include Vaxcyte, Serum Institute of India and Biological E.
Engineering for All offers RevDx™.
Engineering for All has 6 investors. Key investors include Maccabi Health Services, unknown, Arc Impact, Venturing Tech, and eHealth Ventures.